NURO news

Latest 1 stories · newest Jun 12, 2026

NURO

NeuroOne files prospectus supplement for $13.4M equity offering

NeuroOne Medical Technologies filed a prospectus supplement dated June 12, 2026 for an ongoing $13.4M common stock offering under its Capital on Demand Sales Agreement with JonesTrading. The filing represents continued equity financing activity for the medical technology company.

Offering Jun 12, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same NURO feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/NURO/newsSTART FREE